1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Prostate cancer

Degarelix before or with radiotherapy for treating high-risk localised and locally advanced hormone-dependent prostate cancer [ID6419]

In development [GID-TA11443] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 35929-Degarelix-Radiotherapy-for-Prostate-Cancer-V1.0-SEP2023-NON-CONF.pdf (nihr.ac.uk)